Research

Our Webinars

  • The Allergy Equation: Early Bites and Lasting Protection: Can Early Peanut Exposure Shape Lifelong Immunity with Gideon Lack

  • The Allergy Equation: Dissolving fear: The Era of Sublingual Epinephrine with David Golden

  • The Allergy Equation: Dupilumab and the Dual Battle: Fighting Food Allergies and EoE with Jennifer Maloney

  • The Allergy Equation: The Earlier, The Better? Rethinking When We Introduce Allergens with Michael Pistiner

  • The Allergy Equation: Biting Back at Allergies: OIT and the Therapies Making It Possible with Wayne Shreffler

  • The Allergy Equation: OIT vs. SLIT vs. EPIT: A Pill, Drop, or Patch for Food Allergy? with Edwin Kim

  • The Allergy Equation: Reimagine Nasal Epinephrine Spray: A Needle-Free Future for Allergy Emergencies with Sarina Tanimoto

  • The Allergy Equation: New Hope for Food Allergies: What is Changing in Treatment? with CJ Beneduce

  • Project Safe: Plant-Derived Adjuvants & Bioactive Molecules with Beth Sattely, Ph.D.

  • Project Safe: Identification and Acceleration of Adjuvants for Therapeutic Development with Wolfgang Leitner, Ph.D.

  • Project Safe: Selected Effects of Known Chemicals in our Environment with Tim Moran, M.D., Ph.D.

  • Project Safe: Understanding the Effects of Chemicals in our Environment with Andrew Wang, M.D., Ph.D., A.B.

  • Project Safe: Universe of Food Chemicals: Non-Nutritive Chemicals in Our Food with Alberto-László Barabási, Ph.D.

  • Project Safe: Periodic Table of Food Initiative with John de la Parra, Ph.D.,

  • Project Safe: Universe of Food Chemicals Analyzing the Scale of Chemicals in our Environment with Thomas Hartung, M.D., Ph.D.

  • Project Safe: Most Delicious Poison: the Story of Nature’s Toxins from Spices to Vices with Noah Whiteman, Ph.D.

  • Project SAFE Introduction

  • Drug Discovery Accelerator: Unveiling FASI’s Efforts To Catalyze A Cure For Food Allergies

  • Transforming Unprecedented single-cell scale learnings of gut architecture into food allergy therapies.

  • Bugs as drugs: Screening gut microbes for interactions that benefit host immune responses

  • A Conversation about Xolair and its’ Recent Approval for the Treatment of Food Allergies: Discussion with Dr. Dale Umetsu